WEST READING PA – A nationally recognized kidney and liver transplant program, formerly located at the closing Hahnemann University Hospital in Philadelphia, has found a new home at what is being called the Tower Health Transplant Institute. It will operate from the Reading Hospital HealthPlex, and an additional Philadelphia location.
Tower Health, the non-profit healthcare organization that also owns Pottstown Hospital and Phoenixville Hospital, announced the change Thursday (Sept. 12, 2019).
The transplant program team consists of surgeons, hepatologists, and nephrologists who have performed more than 3,000 organ transplants, Tower said. The institute will also include the Center for Liver Disease that was part of Hahnemann, to provide care and therapies to manage and treat a variety of liver diseases.
“With the unfortunate closure of Hahnemann, our goal was to create a home for this nationally-ranked kidney and liver transplant program so it could continue serving patients in eastern Pennsylvania and surroundings areas,” said Clint Matthews, president and CEO of Tower Health. “We are pleased to welcome these 10 outstanding surgeons and physicians, along with experienced clinical and support staff.”
Pending approval by the Unified Network of Organ Sharing, transplants could begin by the end of 2019, Tower said. Outpatient services, such as patient pre-surgical evaluation and monitoring, and transplant follow-up, will begin in later this month.
While at Hahnemann, the transplant program became the only 5-star-rated kidney transplant program in Pennsylvania and the third best kidney transplant program in the nation, as ranked by the Scientific Registry of Transplant Recipients. Its ranking is based on patient survival with a functioning kidney one year after transplant.
Photo from Tower Health